HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health, Beauty And Wellness New Products: Earth Genius, Seedshotz, SimplyProtein, CannaDrink

This article was originally published in The Rose Sheet

Executive Summary

Australian firm introduces US to prebiotic honey; Superfood line offers 10 choices; Crop uses HempOmega in Cannadrink; Aronia berries are Tohi's 'break-out'; more vending machines offer Celsius; MedMen states its brand; Texas CBD firm reaches California; SimplyProtein debuts in US; GNC mines natural market with Earth Genius; and 14 vitamins, minerals in Seedshotz.

You may also be interested in...



Health, Beauty And Wellness Business News: PepsiCo Incubates In Wellness, Cost-Cutting Spurs Profit At FitLife

Harvest Health in cannabidiol wellness with CBx Enterprises; MusclePharm revenues climb 12%; Celsius beverage sales up on retail expansion; CarnoSyn beta-alanine sales drive Natural Alternatives' growth; FitLife shows profit as cost-cutting continues; and PepsiCo incubates wellness start-ups.

Health, Beauty And Wellness Transaction News: SlimFast To Glanbia, More MedMen Moves, Empower Production Partner

Glanbia adds SlimFast to its lineup; MedMen making moves in cannabis market; and production partner for Empower medical cannabis.

South Korea's HK inno.N Targets Cell Therapy, Vaccine Expansion Following $500m IPO

South Korean pharma HK inno.N’s $500m IPO has drawn strong interest with subscriptions from institutional investors marking a record high. The IPO should help it speed up development of cell and gene therapies and beef up its vaccines business.

Topics

UsernamePublicRestriction

Register

RS121862

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel